Recalls / Active ingredient / Rufinamide
Rufinamide
4 FDA drug recalls involving the active ingredient “Rufinamide”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-03-13 | Class II | Rufinamide Tablets 200mg, 120-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pitham | Glenmark Pharmaceuticals Inc., USA |
| 2023-07-21 | Class II | Rufinamide Tablets, USP 200 mg, packaged in 120-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, | Aurobindo Pharma USA Inc. |
| 2023-07-21 | Class II | Rufinamide Tablets, USP 400 mg, packaged in 120-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, | Aurobindo Pharma USA Inc. |
| 2021-03-15 | Class II | Banzel (rufinamide) tablets 200 mg 120 tablets Rx only NDC 62856-582-52 Manufactured by Eisai Co., Ltd. Market | Cardinal Health Inc. |